Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection.

Viruses · 2022 · PMC9147764 · PMID 35632718

Europe PMC DOI

hedged sentence

0.0656

closest p · 1.3× alpha

0.0656

boldest claim

The sentences

approaching significancep = 0.0656so close (0.05 < p ≤ 0.1)

Scores in the Neumifil-treated groups were consistently lower than those for the mock-treated groups, approaching significance on days 5 and 5.5 post-challenge ( p = 0.0656 and p = 0.0547, respectively) but reaching the threshold on days 6.5 and 7 ( p = 0.0104 and p = 0.0374, respectively). 3.2.

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.